Major advances in semaglutide in CKD, approval for lowering cardiovascular risk in type 2 diabetes
Editor's Note: This article has been edited to clarify the title of Dr. Galimella as MBBS, MPH. In an interview with Pharmacy Times®, Pranav Garimella, MBBS, MPH, chief medical officer…